Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D01KYP
|
|||
| Drug Name |
APL-130277
|
|||
| Synonyms |
Apomorphine hydrochloride hemihydrate; UNII-F39049Y068; Apmorphine hydrochloride hemihydrate; Apomorphin hydrochlorid wasser (2/1); Apomorphine hydrochloride [USP]; 6abeta-Aporphine-10,11-diol hydrochloride hemihydrate; Apomorphine hydrochloride hydrate; F39049Y068; Uprima (TN); DSSTox_RID_82721; DSSTox_CID_28159; DSSTox_GSID_48185; Apomorphine hydrochloride (USP); 58-00-4 (Parent); CHEBI:31228; 4H-Dibenzo(de,g)quinoline-10,11-diol, 5,6,6a,7-tetrahydro-6-methyl-, hydrochloride, hydrate
Click to Show/Hide
|
|||
| Indication | Epilepsy [ICD-11: 8A60-8A68] | Phase 3 | [1] | |
| Company |
Aquestive Therapeutics Warren, NJ Sunovion Pharmaceuticals Marlborough, MA
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C34H38Cl2N2O5
|
|||
| Canonical SMILES |
CN1CCC2=C3C1CC4=C(C3=CC=C2)C(=C(C=C4)O)O.CN1CCC2=C3C1CC4=C(C3=CC=C2)C(=C(C=C4)O)O.O.Cl.Cl
|
|||
| InChI |
1S/2C17H17NO2.2ClH.H2O/c2*1-18-8-7-10-3-2-4-12-15(10)13(18)9-11-5-6-14(19)17(20)16(11)12;;;/h2*2-6,13,19-20H,7-9H2,1H3;2*1H;1H2/t2*13-;;;/m11.../s1
|
|||
| InChIKey |
CXWQXGNFZLHLHQ-DPFCLETOSA-N
|
|||
| CAS Number |
CAS 41372-20-7
|
|||
| PubChem Compound ID | ||||
| ChEBI ID |
CHEBI:31228
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.